Business context and reporting period
LightPath Technologies, Inc. manufactures precision molded optics, infrared lenses and assemblies, fiber-optic collimators, GRADIUM lenses and other optical components. This is its Form 10-K for the fiscal year ended June 30, 2014—not a standalone fiscal Q4 filing. The company operates manufacturing facilities in Orlando, Shanghai and, since April 2014, Zhenjiang, China.
Financial performance and position
| Metric | FY2014 | FY2013 |
|---|---|---|
| Revenue | $11.834 million | $11.784 million |
| Gross margin | $5.389 million; 45.5% | $5.175 million; 43.9% |
| Operating income (loss) | $(376,000) | $210,000 |
| Net income (loss) | $(313,000) | $215,000 |
| Net cash from (used in) operations | $(89,000) | $556,000 |
| Capital expenditures | $1.982 million | $1.097 million |
- Cash and cash equivalents were $1.197 million at year-end, including $380,000 held by foreign subsidiaries; working capital was $5.0 million. The company reported a book cash balance of $898,012 on September 1, 2014.
- Equipment advances outstanding under the Avidbank facility were approximately $165,000. No convertible debentures remained outstanding. The Avidbank facility is secured by substantially all company assets; its revolving line limit is up to $1 million, subject to eligible receivables.
- Total liabilities were $3.397 million, including a $731,000 warrant liability, which is a derivative accounting liability rather than borrowing.
- For fiscal Q4, the filing’s quarterly reconciliation reports net income of $102,451, EBITDA of $237,925 and adjusted EBITDA of $(40,258). These are quarterly measures; annual net loss was $313,249.
Material changes versus the prior year
- Revenue was nearly flat, up 0.4%. The prior year included about $481,000 of Raytheon program revenue; LightPath replaced most of that with underlying precision molded optics and infrared sales.
- Gross margin improved to 45.5% from 43.9%, as cost of sales declined despite slightly higher revenue. SG&A increased about $523,000 to $4.51 million, and new product development expense rose about $276,000 to $1.22 million.
- The company moved from net income to a net loss, attributing the decline to investments in product development, personnel, the Zhenjiang facility and manufacturing capacity. Warrant fair-value changes also affected reported results: a $94,000 gain in FY2014 versus a $15,000 loss in FY2013.
- Operating cash flow declined from $556,000 provided to $89,000 used, while inventory increased $1.55 million. Management cited higher tooling inventory, the Zhenjiang start-up and infrared production ramp-up; tooling classification changes accounted for part of the increase.
- Cash financing included $1.539 million net proceeds from warrant exercises and issuance of about 1.136 million shares. Year-end shares outstanding were 14.293 million, versus 12.958 million a year earlier.
Outlook, risks and unusual items
- Management projected FY2015 revenue growth, particularly from precision molded optics for low-cost, high-volume Asian applications, infrared products and redesigned collimators. It expected margin improvement from production transfers to China, productivity and yield gains, lower labor and coating costs, and more in-house coating. These are expectations, not guarantees.
- Management planned approximately $1.40 million of FY2015 product-development spending, with SG&A expected to remain near FY2014 levels; capital spending was expected to be lower, subject to opportunities and circumstances.
- Liquidity is a key risk. At June 30, 2014, LightPath was out of compliance with the Avidbank minimum quick-ratio covenant, although it remained compliant with the debt-service coverage covenant. A September 2, 2014 amendment waived the quick-ratio default and extended the revolving-line maturity to December 30, 2014.
- A proposed private placement with existing shareholder Pudong remained subject to closing conditions, including governmental approvals. It was intended to increase Pudong’s ownership to 19.9%; the initial price was $1.62 per share, subject to adjustment but not below $1.40. The company estimated the interest to be acquired could be worth approximately $3.04 million at the initial price.
- Three customers represented approximately 27% of FY2014 revenue, versus five customers representing 38% in FY2013. Foreign sales were 53% of revenue. Customer concentration, overseas operations, competition, limited capital resources, production ramp execution and availability of certain limited-source materials are notable risks.
- If sales growth and cost-control efforts fail, management said additional capital may be required; unavailable or unreasonable financing could prompt consideration of strategic alternatives. The company reported no current material legal proceedings. Its auditors gave an unqualified opinion on the financial statements; management assessed internal controls as effective, but the auditor did not attest to internal-control effectiveness.
Important facts for investors to verify
- Whether the Pudong placement closed, its final price and share issuance, and the resulting dilution and ownership.
- Subsequent cash, borrowing availability and covenant compliance following the September 2014 waiver and December 30, 2014 line maturity.
- Whether operating cash flow, inventory levels and collections improved; reported DSO was 73 days at FY2014 year-end, against a company target of no more than 65.
- Execution and utilization of the Zhenjiang facility, associated cost savings, product yields, and realization of projected infrared and Asian lens demand.
- The filing gives inconsistent FY2014 average inventory-days figures: the quarterly table shows 158 days, while the accompanying narrative says 188 days. Verify the correct figure.
- Potential dilution from outstanding warrants, options and equity awards, and the ongoing Level 3 warrant-liability remeasurement.